Cloudflare Inc vs Vir Biotechnology Inc. Common Stock — how do they compare? Cloudflare Inc trades at $319.57 (market cap $123.81B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Cloudflare Inc is far larger — about 68.8× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is more actively traded (1,782,836 versus 1,745,042). Which is the better fit depends on your goals — on Pluang, investors hold Cloudflare Inc for 61 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| NET | VIR | |
|---|---|---|
Market Cap | $123.81B | $1.80B |
Volume | 1,745,042 | 1,782,836 |
Sector | Technology | Health |
52-Week High | $361.00 | $11.78 |
52-Week Low | $160.16 | $5.12 |
Typical Hold Time | 61 Days | 0 Days |
Enterprise Value | $123.18B | $1.36B |
Signals from Pluang's Aura AI — not financial advice
Cloudflare (NET) trades at $324.01, down 7.6% over 24 hours, amid a mixed technical and fundamental backdrop. The stock shows a bullish moving average signal but neutral oscillators, with key support at $328. Fundamentally, revenue growth is strong, reaching $2.17B in 2025, but profitability remains a challenge with a net income margin of -8.21%. Recent news highlights product launches like Cloudflare Basin and a partnership with Deutsche Telekom, driving positive sentiment.
The outlook is cautiously optimistic, supported by analyst consensus and strategic initiatives, but high valuation multiples and persistent losses pose risks. Investment opportunity lies in continued top-line expansion and market share gains, while key risks include competitive pressures and execution on path to profitability.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.
Read more on NET →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →